Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Re Directorate

12 Oct 2022 07:00

RNS Number : 5503C
MJ Gleeson PLC
12 October 2022
 

MJ Gleeson plc

("the Company")

(GLE.L)

 

Re Directorate

 

MJ Gleeson plc, the low-cost housebuilder and land promoter, announces that Dermot Gleeson, after 47 years on the Board and 28 years as Chairman, will step down from Board with effect from 31 December 2022.

The Board has concluded an exhaustive search process and is pleased to announce that James Thomson, CEO until 31 December 2022 and who had accepted an invitation to subsequently remain on the Board as a non-executive Director, will succeed Dermot as non-executive Chairman with effect from 1 January 2023.

Fiona Goldsmith, Senior Independent Director, commented:

"The Board would like to put on record its heartfelt thanks to Dermot for the enormous contribution to the business that he has made over many years and which have seen some of the most testing times experienced across the UK housebuilding sector. It was his vision that saw the business transformed into the UK's leading listed low-cost housebuilder and a business that can genuinely say that it changes people's lives.

"We are delighted that James will succeed Dermot. He has a long and outstanding track record in the housebuilding sector and, of course, a deep knowledge of Gleeson. This will provide much stability, both in these volatile times and as we welcome Graham Prothero as our new CEO at the beginning of next year."

Dermot Gleeson, Chairman, commented:

"I will be leaving the business in good shape and in good hands. I am extremely proud of what has been achieved by the wider Gleeson team throughout my time as Chairman and I look forward to watching with interest and excitement the continued growth of the business as it continues to play a leading role in meeting the enormous demand from first-time buyers for an affordable home."

As previously announced, a search process is underway for an additional non-executive Director and the Board expects to make an appointment before the end of the year.

The next trading update will be issued on the morning of the Company's Annual General Meeting on 18 November 2022 and a trading update in respect of H1 FY2023 will be issued on 13 January 2023.

 

ENDS

 

This announcement is made in accordance with Rule 9.6.14 of the UK Listing Rules.

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Leanne Johnson, Company Secretary.

 

LEI: 21380064K7N2W7FD6434

12 October 2022

Enquiries:

MJ Gleeson plc

Leanne Johnson, Head of Legal & Company Secretary Tel: +44 1142 612900

 

Hudson Sandler

Mark Garraway Tel: +44 7771 860938

Charlotte Cobb Tel: +44 7795 422131

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKEFFSKAFFA
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.